Viking Therapeutics (VKTX) Other Gross PP&E Adjustments (2019 - 2025)
Viking Therapeutics (VKTX) has disclosed Other Gross PP&E Adjustments for 7 consecutive years, with -$224000.0 as the latest value for Q4 2025.
- For Q4 2025, Other Gross PP&E Adjustments rose 85.3% year-over-year to -$224000.0; the TTM value through Dec 2025 reached -$224000.0, up 85.3%, while the annual FY2025 figure was -$224000.0, 85.3% up from the prior year.
- Other Gross PP&E Adjustments hit -$224000.0 in Q4 2025 for Viking Therapeutics, up from -$797000.0 in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at -$54000.0 in Q4 2021 and bottomed at -$1.9 million in Q2 2022.
- Average Other Gross PP&E Adjustments over 5 years is -$1.1 million, with a median of -$1.3 million recorded in 2024.
- Year-over-year, Other Gross PP&E Adjustments surged 91.87% in 2021 and then tumbled 3168.52% in 2022.
- Viking Therapeutics' Other Gross PP&E Adjustments stood at -$54000.0 in 2021, then plummeted by 3168.52% to -$1.8 million in 2022, then grew by 15.98% to -$1.5 million in 2023, then fell by 2.76% to -$1.5 million in 2024, then skyrocketed by 85.3% to -$224000.0 in 2025.
- According to Business Quant data, Other Gross PP&E Adjustments over the past three periods came in at -$224000.0, -$797000.0, and -$809000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.